Article: Eden Biodesign, operator of the UK National Biomanufacturing Centre (NBC) (Liverpool), and IntelliHep, the heparin-based drug development company located in the MerseyBIO Incubator (Liverpool) are to develop a large-scale manufacturing process.(Projects & Technology)(Brief article)

Eden Biodesign, operator of the UK National Biomanufacturing Centre (NBC) (Liverpool), and IntelliHep, the heparin-based drug development company located in the MerseyBIO Incubator (Liverpool) are to develop a large-scale manufacturing process for heparin-based treatments for ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!